| scholarly article | Q13442814 |
| P50 | author | Suoma E Saarni | Q114366490 |
| Krista Partti | Q114366491 | ||
| Jonna Perälä | Q24064572 | ||
| Jouko Lönnqvist | Q29840812 | ||
| Jari Haukka | Q30348354 | ||
| Satu Viertiö | Q37828404 | ||
| Jaana Suvisaari | Q39998334 | ||
| P2093 | author name string | Antti Jula | |
| Samuli I Saarni | |||
| Britt-Marie Loo | |||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | psychosis | Q170082 |
| inflammation | Q101991 | ||
| P304 | page(s) | 305-311 | |
| P577 | publication date | 2011-07-27 | |
| P1433 | published in | Psychiatry Research | Q15750888 |
| P1476 | title | Inflammation in psychotic disorders: a population-based study. | |
| P478 | volume | 189 |
| Q36600804 | A Review of Brain-derived Neurotrophic Factor as a Candidate Biomarker in Schizophrenia |
| Q48063321 | A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression |
| Q36914697 | A significant causal association between C-reactive protein levels and schizophrenia |
| Q35603078 | Altered activation of innate immunity associates with white matter volume and diffusion in first-episode psychosis |
| Q43213613 | Association between C-reactive protein and risk of schizophrenia: An updated meta-analysis |
| Q38394902 | Biological aspects and candidate biomarkers for psychotic bipolar disorder: A systematic review |
| Q58712660 | C-Reactive Protein as a Peripheral Biomarker in Schizophrenia. An Updated Systematic Review |
| Q36190768 | C-reactive protein concentrations across the mood spectrum in bipolar disorder: a systematic review and meta-analysis |
| Q50578956 | C-reactive protein is increased in schizophrenia but is not altered by antipsychotics: meta-analysis and implications. |
| Q35965185 | Clinical correlates of vitamin D deficiency in established psychosis. |
| Q43997962 | Different changes in cortical tumor necrosis factor-α-related pathways in schizophrenia and mood disorders |
| Q34048554 | Elevated C-reactive protein associated with late- and very-late-onset schizophrenia in the general population: a prospective study |
| Q90450419 | Excess mortality in severe mental illness: more questions than answers |
| Q33990603 | Increased M1/decreased M2 signature and signs of Th1/Th2 shift in chronic patients with bipolar disorder, but not in those with schizophrenia |
| Q45354410 | Increased risk of hepatitis E virus infection in schizophrenia |
| Q36377907 | Inflammatory Markers in Recent Onset Psychosis and Chronic Schizophrenia |
| Q26827995 | Late-onset schizophrenia: do recent studies support categorizing LOS as a subtype of schizophrenia? |
| Q38226495 | Neuroimmunomodulation in depression: a review of inflammatory cytokines involved in this process |
| Q33353554 | Neuroinflammation and non-motor symptoms: the dark passenger of Parkinson's disease? |
| Q48231943 | Persistent inflammation and its relationship to leptin and insulin in phases of bipolar disorder from acute depression to full remission. |
| Q31055209 | Progranulin gene variability and plasma levels in bipolar disorder and schizophrenia |
| Q36580013 | Shared Immune and Repair Markers During Experimental Toxoplasma Chronic Brain Infection and Schizophrenia |
| Q37537915 | Subclinical elevation of plasma C-reactive protein and illusions/hallucinations in subjects with Parkinson's disease: case-control study |
| Q38797294 | The known and missing links between Toxoplasma gondii and schizophrenia. |
| Q33624412 | Theranostic Biomarkers for Schizophrenia |
| Q30440507 | Viral infection, inflammation and schizophrenia |
Search more.